http://billmoyers.com/segment/u-s-rep-peter-welch-on-amgen%e2%80%99s-sweet-senate-deal/
January 25, 2013
A recent article in The New York Times reported on a cost-control exception provided to Amgen, the world’s largest biotechnology firm. According to the report, the sweetheart deal — hidden in the Senate’s final “fiscal cliff” bill — will cost taxpayers half a billion dollars. Bill talks to U.S. Representative Peter Welch (D-VT) about the bi-partisan bill he recently sponsored to repeal that giveaway, and the political factors that allow such crony capitalism to occur.
Environmental Justice http://courses.dce.harvard.edu/~envre145
Environment Ethics http://courses.dce.harvard.edu/~envre120
health
Transition Studies 